Viral peptide–major histocompatibility complex complex

A **viral peptide–major histocompatibility complex (MHC) complex** refers to a molecular structure formed when a short peptide derived from a viral protein is bound within the peptide-binding groove of an MHC molecule (either class I or class II), and displayed on the surface of a host cell[2][3][1]. The primary biological function of such complexes is to enable the immune system, specifically T cells, to discriminate between self and nonself by presenting these peptide antigens for recognition by T cell receptors (TCRs)[3][2][5][4]. Recognition of viral peptide–MHC complexes by cytotoxic T lymphocytes leads to the targeted killing of virus-infected cells[5]. The diversity of MHC molecules and the ability to present a broad repertoire of peptides are driven by strong evolutionary pressure from pathogens[2][3]. Structurally, these complexes have been extensively characterized, and the interaction of the peptide within the MHC groove is key for T cell recognition and immune activation[6][5]. Due to the highly polymorphic nature of MHC molecules, the efficiency and specificity of immune responses to viral infections and cancer vary between individuals. The peptide–MHC complex is a central focus in immunotherapy, vaccine development, and biomarker discovery, but presents challenges such as immune escape and HLA restriction[4][5][2].

Other names

Peptide–MHC complexAntigen–MHC complexViral peptide in MHCPeptide–major histocompatibility complex complex

Presentation of viral (or otherwise foreign) peptides to T cell receptors, triggering a cytotoxic T cell response against infected or abnormal cells; Basis for T cell–mediated recognition (immunotherapy exploits T cell activation via peptide–MHC recognition)[5][4][2]